US Stock MarketDetailed Quotes
MBX MBX Biosciences
- 16.950
- +0.530+3.23%
Trading Nov 19 10:56 ET
566.43MMarket Cap-10254P/E (TTM)
17.780High15.720Low14.47KVolume15.720Open16.420Pre Close241.55KTurnover0.14%Turnover RatioLossP/E (Static)33.42MShares27.50052wk High2.09P/B172.89MFloat Cap15.63052wk Low--Dividend TTM10.20MShs Float27.500Historical High--Div YieldTTM12.55%Amplitude15.630Historical Low16.688Avg Price1Lot Size
About MBX Biosciences Company
MBX Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of peptide therapies for the treatment of endocrine and metabolic disorders. Its product candidates and programs include MBX 2109, MBX 1416, and obesity portfolio. The company was founded by Peter Kent Hawryluk and Richard D. DiMarchi in August 2018 and is headquartered in Carmel, IN.
Company Profile
SymbolMBX
Company NameMBX Biosciences
Listing DateSep 13, 2024
Issue Price16.00
Founded2018
CEOMr. Peter Kent Hawryluk
MarketNASDAQ
Employees36
Fiscal Year Ends12-31
Address11711 North Meridian Street,Suite 300
CityCarmel
ProvinceIndiana
CountryUnited States of America
Zip Code46032
Phone1-317-659-0200
Websitehttp://www.mbxbio.com
Company Executives
- Name
- Position
- Salary
- Peter Kent Hawryluk
- President, Chief Executive Officer and Director
- 4.86M
- Richard B. Bartram
- Chief Financial Officer and Principal Accounting Officer
- 1.05M
- Dr. Salomon Azoulay, M.D.
- Chief Medical Officer
- --
- Dr. Steven Ryder, M.D.
- Independent Director
- --
- Dr. Ora H. Pescovitz, M.D.
- Independent Director
- --
- Dr. Carl L. Gordon, C.F.A.,PhD
- Independent Director
- --
- Patrick J. Heron
- Independent Director
- --
- James M. Cornelius
- Independent Director
- --
- Edward T. Mathers
- Independent Director
- --
- Dr. Tiba Aynechi, PhD
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
